Reconsidering Physician-Pharmaceutical Industry Relationships

JAMA. 2017 May 2;317(17):1772-1773. doi: 10.1001/jama.2017.4455.

Authors

Colette DeJong¹, R Adams Dudley²

Affiliations

¹ Center for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, School of Medicine, University of California, San Francisco.
² Center for Healthcare Value, Philip R. Lee Institute for Health Policy Studies, School of Medicine, University of California, San Francisco2Department of Medicine, School of Medicine, University of California, San Francisco.

PMID: 28464124
DOI: 10.1001/jama.2017.4455

No abstract available

Publication types

Editorial
Comment

MeSH terms

Conflict of Interest
Drug Industry*
Humans
Physicians*